Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses

Michael Donkor, Jamie Choe, Danielle Marie Reid, Byron Quinn, Mark Pulse, Amalendu Ranjan, Pankaj Chaudhary, Harlan P. Jones

Open source

DOI
10.3390/pharmaceutics15020445
Published
2023-01-29
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15020445,
  title = {Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses},
  author = {Michael Donkor and Jamie Choe and Danielle Marie Reid and Byron Quinn and Mark Pulse and Amalendu Ranjan and Pankaj Chaudhary and Harlan P. Jones},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15020445},
  url = {https://doi.org/10.3390/pharmaceutics15020445}
}

RIS

TY  - JOUR
TI  - Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses
AU  - Michael Donkor
AU  - Jamie Choe
AU  - Danielle Marie Reid
AU  - Byron Quinn
AU  - Mark Pulse
AU  - Amalendu Ranjan
AU  - Pankaj Chaudhary
AU  - Harlan P. Jones
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15020445
UR  - https://doi.org/10.3390/pharmaceutics15020445
ER  - 

APA

Donkor, M., Choe, J., Reid, D. M., Quinn, B., Pulse, M., Ranjan, A., Chaudhary, P., & Jones, H. P. (2023). Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15020445

Source records